Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

NCT07593885 is registered in ClinicalTrials.gov with Dr. Gerhard Mann chem.-pharm. Fabrik GmbH as lead sponsor.

NCT NCT07593885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease
Lead sponsor
Dr. Gerhard Mann chem.-pharm. Fabrik GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2026
Completion date
November 30, 2026
Enrollment
160 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye